CC
The Chemours Company
CC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
CC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Weak |
CC's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is weak.
CC PE Valuation
CC has no meaningful PE right now: it lost money over the past year.
CC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CC's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.56 | — |
| Q3 2026 | -$1.02 | +$1.20 |
| Q2 2026 | -$1.91 | +$0.89 |
| Q1 2026 | -$2.64 | -1420% |
| Q4 2025 | -$2.48 | -535% |
| Q3 2025 | -$2.22 | -544% |
| Q2 2025 | -$2.80 | -446% |
| Q1 2025 | $0.20 | +$2.37 |
| Q4 2024 | $0.57 | +$2.12 |
CC is still losing money, but far less than before: $1.02 per share over the past year, against $2.80 at its worst in mid-2025.
CC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +3% |
| Q2 2026 | $1.6B | -1.5% |
| Q1 2026 | $1.4B | +1% |
| Q4 2025 | $1.3B | -2.2% |
| Q3 2025 | $1.5B | -0.4% |
| Q2 2025 | $1.6B | +5% |
| Q1 2025 | $1.4B | +1.3% |
| Q4 2024 | $1.4B | -0.1% |
CC's revenue fell from its 2022 peak and has held roughly level since: $1.5B last quarter, up 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +11 points |
| Q2 2026 | -0.1% | +16 points |
| Q1 2026 | -1.6% | N/A |
| Q4 2025 | -5% | -5.7 points |
| Q3 2025 | 3.4% | +5.4 points |
| Q2 2025 | -16% | -22 points |
| Q4 2024 | 0.7% | +5.9 points |
| Q3 2024 | -2% | -3.5 points |
CC's operating margin was 14% last quarter, up 11 points from the same quarter a year ago.
CC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $98M | -6.7% |
| Q2 2026 | $114M | +128% |
| Q1 2026 | -$93M | +$103M |
| Q4 2025 | $92M | +217% |
| Q3 2025 | $105M | +67% |
| Q2 2025 | $50M | +$743M |
| Q1 2025 | -$196M | +$196M |
| Q4 2024 | $29M | -92% |
CC's free cash flow has turned positive again: $211M over the past year, against −$12M the year before.
CC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.0x | High |
| Q2 2026 | 11.4x | High |
| Q1 2026 | 111.7x | High |
| Q4 2024 | 7.9x | High |
| Q3 2024 | 10.0x | High |
| Q2 2024 | 8.6x | High |
| Q3 2023 | 3,115.0x | High |
| Q2 2023 | 10.6x | High |
CC's net debt is about 7.0 years of its operating earnings (EBITDA), down from 10 years a year ago.
CC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.2 | Neutral |
| Stochastic | 16.5 | Oversold |
CC's weekly RSI is 37 (neutral) and its Stochastic is 17 (oversold).
CC PE vs Basic Materials Sector
| Metric | CC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
CC has no meaningful PE right now: it lost money over the past year.
CC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.4 | 0.1% below |
| 20 week MA | $15.2 | 12% below |
| 50 week MA | $17.4 | 23% below |
| 100 week MA | $15.7 | 15% below |
| 200 week MA | $21.6 | 38% below |
CC is in a downtrend: it's below all five of its weekly moving averages, and 38% below its 200-week average.
CC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.6 | $26.9 | +53% |
| 2021 | $26.9 | $31.7 | +18% |
| 2022 | $31.7 | $30.8 | -3% |
| 2023 | $30.8 | $31.5 | +2.5% |
| 2024 | $31.5 | $17.0 | -46% |
| 2025 | $17.0 | $12.1 | -29% |
| 2026 YTD | $12.1 | $13.4 | +10% |
CC has finished lower in three of the last six years. It's up 10% so far in 2026.